Failure is not an option Although success was never guaranteed for Taiwan’s early tech pioneers, failure was unthinkable. With U.S. economic aid, once equivalent to 6% of GDP, coming to an end, and ...

台灣美國商會於6月在華盛頓特區的會議中了解了《台灣盟友基金法案》，這項跨黨派立法提案計劃在三年內撥款1.2億美元，用於協助面臨中國壓力的台灣夥伴，並強化台灣的全球盟友連結。法案旨在通過財務支持和鼓勵供應鏈多元化，來對抗北京的外交孤立策略，並促進台灣在國際論壇上的參與 ...

IDC InfoBrief: sponsored by Microsoft, 2024 Business Opportunity of AI, IDC# US52699124, November 2024 IDC’s findings align with what Microsoft is seeing as we work with companies across industries to ...

Although newly appointed AmCham Taiwan President Carl Wegner is a recent arrival to both the Chamber and Taiwan, he is a stranger to neither. A veteran executive with more than three decades of ...

Taiwan Business TOPICS is published monthly by the American Chamber of Commerce in Taiwan. Besides the online version, hard copies can be ordered on an annual subscription basis. Three special issues ...

Since its launch in 1995, Taiwan’s National Health Insurance (NHI) program has become globally recognized as a model of success. Centered on fairness, mutual assistance, and affordability, the NHI ...

自1995年實施以來，台灣的全民健康保險（健保）制度已成為全球公認的成功典範。以公平、互助及負擔得起為核心，健保旨在確保全民皆能享有醫療服務，同時減輕因病致貧的經濟壓力。在過去30年間，健保不僅提升了全民健康，也對台灣的社會穩定與經濟發展做出了重大貢獻。 健保制度的貢獻 ...

嬌生創新製藥台灣總經理 Jayashri Kulkarni 表示：「嬌生相信健康就是一切。我們融合真心、科學與創造力，為全人類健康帶來深遠的影響。」嬌生持續在各產業中的研發投資名列前茅，2024 年全公司在研發領域的投資金額達 172 億美元。 台灣壯生醫療器材總經理山本英右表示：「我們聚焦的重點，在於 ...

As populations age and chronic diseases emerge earlier and more pervasively, Taiwan is stepping forward with bold, collaborative solutions. The newly announced T-CaReMe – short for Taipei ...

Johnson & Johnson Taiwan is advancing healthcare through groundbreaking innovations in medicine and MedTech, while championing faster access, patient-centered care, and workforce development. From ...